Ming-Chin Lee

1.6k total citations
30 papers, 1.2k citations indexed

About

Ming-Chin Lee is a scholar working on Immunology, Oncology and Rheumatology. According to data from OpenAlex, Ming-Chin Lee has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 11 papers in Oncology and 6 papers in Rheumatology. Recurrent topics in Ming-Chin Lee's work include Immune cells in cancer (11 papers), Chemokine receptors and signaling (9 papers) and Immune Response and Inflammation (9 papers). Ming-Chin Lee is often cited by papers focused on Immune cells in cancer (11 papers), Chemokine receptors and signaling (9 papers) and Immune Response and Inflammation (9 papers). Ming-Chin Lee collaborates with scholars based in Australia, United States and Germany. Ming-Chin Lee's co-authors include John A. Hamilton, Adrian Achuthan, Andrew J. Fleetwood, Andrew D. Cook, Burkhard Becher, John R. Teijaro, Frederick Lang, Reem Saleh, Irmgard Förster and Andrew Murphy and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Ming-Chin Lee

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming-Chin Lee Australia 19 534 301 182 170 126 30 1.2k
Ghasem Solgi Iran 20 392 0.7× 291 1.0× 162 0.9× 92 0.5× 103 0.8× 93 1.3k
Sujata Sarkar United States 14 1.0k 1.9× 253 0.8× 279 1.5× 309 1.8× 125 1.0× 21 1.6k
Joanne Smith United Kingdom 7 705 1.3× 527 1.8× 194 1.1× 101 0.6× 175 1.4× 8 1.5k
Adrian Achuthan Australia 24 1.1k 2.1× 542 1.8× 387 2.1× 207 1.2× 152 1.2× 45 2.0k
Mila Fernandes Moreira Madeira Brazil 19 204 0.4× 320 1.1× 120 0.7× 118 0.7× 85 0.7× 37 938
Hekla Sigmundsdóttir Iceland 14 1.2k 2.3× 222 0.7× 258 1.4× 143 0.8× 231 1.8× 21 1.9k
Rille Pullerits Sweden 22 596 1.1× 394 1.3× 77 0.4× 229 1.3× 97 0.8× 67 1.5k
Gayle Callis United States 16 544 1.0× 311 1.0× 92 0.5× 72 0.4× 290 2.3× 25 1.1k
Carla Guthridge United States 10 511 1.0× 302 1.0× 168 0.9× 197 1.2× 77 0.6× 19 1.1k
Przemysław Lewkowicz Poland 21 761 1.4× 269 0.9× 112 0.6× 70 0.4× 116 0.9× 67 1.5k

Countries citing papers authored by Ming-Chin Lee

Since Specialization
Citations

This map shows the geographic impact of Ming-Chin Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Chin Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Chin Lee more than expected).

Fields of papers citing papers by Ming-Chin Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming-Chin Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Chin Lee. The network helps show where Ming-Chin Lee may publish in the future.

Co-authorship network of co-authors of Ming-Chin Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Ming-Chin Lee. A scholar is included among the top collaborators of Ming-Chin Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming-Chin Lee. Ming-Chin Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yukuan, et al.. (2025). Screening of the FDA-approved drug library identifies CCL17 inhibitors that block arthritic pain. Scientific Reports. 15(1). 26734–26734.
2.
Lee, Ming-Chin, et al.. (2024). IL-23p19 in osteoarthritic pain and disease. Osteoarthritis and Cartilage. 32(11). 1413–1418. 1 indexed citations
3.
Lee, Ming-Chin, John A. Hamilton, Hong‐Jian Zhu, et al.. (2024). Signaling pathways underlying TGF-β mediated suppression of IL-12A gene expression in monocytes. Molecular Immunology. 166. 101–109. 5 indexed citations
4.
Lee, Ming-Chin, Leon Chang, Carl L. Manthey, et al.. (2024). IL-23 regulation of myeloid cell biology during inflammation. Cytokine. 179. 156619–156619. 1 indexed citations
5.
Achuthan, Adrian, Mark Biondo, Bronwyn A. Kingwell, et al.. (2023). The GM-CSF/CCL17 pathway in obesity-associated osteoarthritic pain and disease in mice. Osteoarthritis and Cartilage. 31(10). 1327–1341. 6 indexed citations
6.
Hamilton, John A., et al.. (2023). CCL17/TARC in autoimmunity and inflammation—not just a T‐cell chemokine. Immunology and Cell Biology. 101(7). 600–609. 30 indexed citations
7.
Lee, Ming-Chin, Andrew J. Fleetwood, Andrew D. Cook, et al.. (2023). Epigenetic and transcriptional regulation of CCL17 production by glucocorticoids in arthritis. iScience. 26(10). 108079–108079. 4 indexed citations
8.
Lee, Ming-Chin, Adrian Achuthan, David P. De Souza, et al.. (2022). Type I interferon antagonism of the JMJD3-IRF4 pathway modulates macrophage activation and polarization. Cell Reports. 39(3). 110719–110719. 36 indexed citations
9.
Achuthan, Adrian, Ming-Chin Lee, & John A. Hamilton. (2021). Targeting GM-CSF in inflammatory and autoimmune disorders. Seminars in Immunology. 54. 101523–101523. 47 indexed citations
10.
Lang, Frederick, Ming-Chin Lee, John R. Teijaro, Burkhard Becher, & John A. Hamilton. (2020). GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches. Nature reviews. Immunology. 20(8). 507–514. 153 indexed citations
11.
Lee, Ming-Chin, et al.. (2020). Targeting GM-CSF for collagenase-induced osteoarthritis pain and disease in mice. Osteoarthritis and Cartilage. 28(4). 486–491. 37 indexed citations
12.
Lee, Ming-Chin, Zihao Zhang, Adrian Achuthan, et al.. (2020). IL-23 in arthritic and inflammatory pain development in mice. Arthritis Research & Therapy. 22(1). 123–123. 18 indexed citations
13.
Lee, Ming-Chin, Adrian Achuthan, & John A. Hamilton. (2020). <p>GM-CSF: A Promising Target in Inflammation and Autoimmunity</p>. ImmunoTargets and Therapy. Volume 9. 225–240. 92 indexed citations
14.
Cook, Andrew D., Ming-Chin Lee, Anne Deen Christensen, et al.. (2020). Granulocyte-Macrophage Colony Stimulating Factor As an Indirect Mediator of Nociceptor Activation and Pain. Journal of Neuroscience. 40(11). 2189–2199. 23 indexed citations
15.
Souza, David P. De, Adrian Achuthan, Man K.S. Lee, et al.. (2019). Autocrine IFN-I inhibits isocitrate dehydrogenase in the TCA cycle of LPS-stimulated macrophages. Journal of Clinical Investigation. 129(10). 4239–4244. 56 indexed citations
16.
Lee, Ming-Chin, et al.. (2018). Epigenetic and transcriptional regulation of IL4-induced CCL17 production in human monocytes and murine macrophages. Journal of Biological Chemistry. 293(29). 11415–11423. 44 indexed citations
17.
Cook, Andrew D., Ming-Chin Lee, Reem Saleh, et al.. (2018). TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17. JCI Insight. 3(6). 44 indexed citations
18.
Lee, Ming-Chin, Reem Saleh, Adrian Achuthan, et al.. (2018). CCL17 blockade as a therapy for osteoarthritis pain and disease. Arthritis Research & Therapy. 20(1). 62–62. 76 indexed citations
19.
Fleetwood, Andrew J., Man K.S. Lee, William Singleton, et al.. (2017). Metabolic Remodeling, Inflammasome Activation, and Pyroptosis in Macrophages Stimulated by Porphyromonas gingivalis and Its Outer Membrane Vesicles. Frontiers in Cellular and Infection Microbiology. 7. 351–351. 166 indexed citations
20.
Lee, Ming-Chin, et al.. (2014). Aloin-induced cell growth arrest, cell apoptosis, and autophagy in human non-small cell lung cancer cells. 6(4). 144–149. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ghasem Solgi Breakdown of academic impact, for papers by Sujata Sarkar Breakdown of academic impact, for papers by Joanne Smith Breakdown of academic impact, for papers by Adrian Achuthan Breakdown of academic impact, for papers by Mila Fernandes Moreira Madeira Breakdown of academic impact, for papers by Hekla Sigmundsdóttir Breakdown of academic impact, for papers by Rille Pullerits Breakdown of academic impact, for papers by Gayle Callis Breakdown of academic impact, for papers by Carla Guthridge Breakdown of academic impact, for papers by Przemysław Lewkowicz
Rankless by CCL
2026